| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0057 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.0058 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |